Chemical diversity is at the heart of both genetics and pharmacology. Changes to DNA or small molecule Genetics is the dominant tool and paradigm for understructure control biological function. In the case of standing biology. However, there are limitations to the chemistry, we refer to the diversity of structures. In the power of genetics. Even though E. coli has been geneticase of genetics, we refer to sequence variation. cally manipulatable for over 50 years, about one-third Hence, diversity serves as a common benchmark for of E. 
Gross, personal Communication).
What lessons do these papers provide for future chemical genetic studies? A particularly surprising lesson to me was the utility of a molecule to probe some aspect of cell function other than the actual "target" of the small molecule, i.e., the enzyme active site. Traditional pharmacology teaches us to think of inhibitors as binding to an active site, lock and key, but we forget that molecules must pass through cellular membranes and may do so through interaction with specific protein or lipid components. Thus small molecules can be used to probe these membrane-proximal events and give insight into machines in the membrane that may have eluded study with genetics alone.
Finally, biology is not simply DNA-RNA-protein, but small molecules are intimate components and substrates for natural evolution ( Figure 1I) . Thus, many of the proteins and molecular machines we study in biology are designed to be regulated by naturally occurring small molecules (nucleotides, cofactors, lipids, etc.). Therefore it stands to reason that we must use small molecule tools to appropriately and completely study the machines in order to better understand biology (Clardy and Walsh, 2004).
